Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer
Takahisa Yamashita(Saitama Medical University), Jun‐ichi Tamaru(Social Insurance Saitama Chuo Hospital)
Cited by 30
Related Papers
High-grade Lung Adenocarcinoma With Fetal Lung–like Morphology
|The American Journal of Surgical Pathology|2013|74
Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder Cancer
|Pathology International|2025|2